Chicago-based Valence Health, a provider of clinical integration, population health and value-based care solutions and services, has appointed R. Andrew Eckert CEO.
Here are four things to know about Mr. Eckert.
1. He will join the company effective Aug. 3.
2. Mr. Eckert is joining Valence Health at the same time that the company announced that revenues grew more than 55 percent over the last 12 months compared to the 12 months prior. To support this record growth, the company has added more than 300 employees in the past year, and expects to have 1,000 employees serving 120 clients by year-end.
3. As CEO, Mr. Eckert will help Valence Health "further advance its vision and capabilities in response to high client demand," the company said. He replaces Phil Kamp, who has served as CEO since founding Valence Health in 1996. Mr. Kamp will step into a new role as chief strategy officer. Co-founder Todd Stockard will remain the company's president.
4. Previously, Mr. Eckert served as the CEO of numerous private and public companies including TriZetto, Eclipsys, CRC Health and ADAC Laboratories.